Breast Cancer Initiative 2.5 (BCI2.5)


The BCI2.5 strategy consists of the following components:


BCI2.5 utilizes existing meetings and conferences to build relationships, recognition and support for the BCI2.5 campaign to reduce disparities in outcomes for 2.5 million women by 2025. BCI2.5 engages regional alliances, organizations, experts and advocates to assess specific needs and to determine how BCI2.5 technical expertise can be leveraged most effectively and appropriately. BCI2.5 can also act as a convener or catalyst to support and advocate for regional alliances.

Tools, innovation and information

  • Tools
    BCI2.5 is developing situation analyses tools to aid countries in assessing need and identifying bottlenecks in breast health care delivery. BCI2.5 is also developing models to estimate the impact of providing early diagnosis and treatment interventions in different resource settings. These models will assist in determining the most effective and appropriate interventions in specific settings given available resources.
  • Innovation
    BCI2.5 seeks to support innovative approaches to addressing breast health care in low-resource settings by linking partners and developing a library of case studies featuring innovative evidence-based approaches to breast health care in different resource settings and facilitating their dissemination.
  • Information
    BCI2.5 is building an online library featuring Knowledge Summaries, Case Studies and other educational resources.

Global Breast Health Analytics Map (GloBAM)

GloBAM is an interactive data visualization tool for analyzing the determinants of the global breast cancer burden. GloBAM provides a means for linking data on breast cancer incidence and mortality, health spending, cancer policies and practices, determinants of health and more by country. This innovative tool harnesses a wealth of data regarding breast cancer care worldwide and is vital to mapping health system resource levels, identifying gaps in breast health care and shaping resource-appropriate solutions. Data will be updated to reflect new data releases from IARC, the World Bank, WHO, IHME and other sources. GloBAM is essential tool in producing informed situation analyses of breast health care systems and serves as a platform for tracking measurable outcomes. 

Baseline Assesments/Situation Analyses

In collaboration with partner countries or centers of excellence, BCI2.5 is supporting baseline assessments and situation analyses utilizing the BCI2.5 self-assessment tools, Global Breast Health Analytics Map (GloBAM), stakeholder mapping, focus groups and other methods as appropriate.

Breast Cancer Action Plans

BCI2.5 seeks opportunities to partner and engage with others through forums that bring together multidisciplinary country teams of policy makers, cancer center representatives, clinicians, advocates and other stakeholders to review their situation analyses. Through a collaborative process BCI2.5 supports teams in developing resource-appropriate action plans to assist countries in the decision-making process and outline next steps in implementing improvements in breast health care.

BCI2.5 Master Courses

BCI2.5 is developing modular curriculum units using the above mentioned tools and resources. Courses will target advocates, policy makers and clinicians. Materials will be available online via the BCI2.5 website.

Technical Assistance and Implementation Research

 BCI2.5 works collaboratively with partner organizations and countries to facilitate implementation of evidence-based breast health care programs for scale-up, and develop metrics and implementation science methodology to evaluate plan implementation, and to assess systems-based outcomes.

As an advocate in low and middle income countries where breast cancer patients and the population are still struggling with stigma, lack of awareness about the importance of screening, early treatment, supportive care services and limited Government commitment to cancer control,  BCI2.5 is vital in our efforts to bridge the  information  gap between patients, providers, clinicians, policy makers and resource allocation. The strategy of multidisciplinary engagement is a powerful tool in building the capacity of  advocates in this part of the world to develop innovative pathways to reduce breast cancer outcomes for 2.5 million women by 2025.

- Gertrude Nakigudde, Executive Director, Uganda Women's Cancer Support Organisation (UWOCASO)